ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced the first commercial cases in the United ...

SMH is among the first offering the new Hydros Robotics System for Aquablation therapy.

Our extensive research on the Benign Prostatic Hyperplasia Treatment (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, in ...

The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...

UCHealth hospital uses BPH AI to guide aquablation, improving precision and preserving sexual function in prostate treatment.

Butterfly Medical announced that it completed the final 12-month follow-up for all patients in a study of its prostatic ...

TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has unveiled groundbreaking results from the CLEAR study, the first head-to-head randomized controlled trial comparing the UroLift™ System with Rezūm™ ...

Enlarged prostate, also known as benign prostatic hyperplasia (BPH), is a common condition that affects about 50% of men by age 60 and up to 90% of men by age 85. 1 As men age, the prostate can grow ...

Drug therapy for BPH can be categorized into two groups: agents that interfere with testosterone's stimulatory effect on prostate enlargement and agents that relax prostatic smooth muscle. Of the ...

Enlarged prostate, also known as benign prostatic hyperplasia (BPH), is a common condition that affects about 50% of men by age 60 and up to 90% of men by age 85. 1 As men age, the prostate can grow ...